Literature DB >> 1363222

Anaesthetic management of a parturient with myocardial infarction related to cocaine use.

S S Liu1, R M Forrester, G S Murphy, K Chen, R Glassenberg.   

Abstract

Cocaine abuse is common among parturients with an incidence of 11.8 to 20%. Myocardial infarction is a rare and lethal event during pregnancy with an incidence of 1 in 10,000 pregnancies. We present the anaesthetic management of a parturient of 36 wk gestation who suffered a myocardial infarction nine hours before delivery which was temporally related to "crack" cocaine use. The patient's cardiovascular system became unstable following cocaine use, and she required mechanical ventilatory support and pharmacologic stabilization guided by invasive haemodynamic monitoring. This patient survived a non-Q wave myocardial infarction, but the prognosis of peripartum myocardial infarction remains poor with a mortality rate of 30-40% which is increased if the infarction occurs in the third trimester or postpartum period. The optimal mode and timing of delivery after myocardial infarction is unresolved. The association between cocaine use and myocardial infarction was first described in 1982, and cocaine remains unique among local anaesthetics in its ability to compromise the cardiovascular system through both sympathomimetic effects and vasoconstrictive effects on coronary arteries. Because of the prevalence of substance abuse, cocaine use should be considered in the differential diagnosis of sudden cardiovascular compromise in parturients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1363222     DOI: 10.1007/BF03008297

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  27 in total

1.  CAN THE RISKS OF MYOCARDIAL INFARCTION IN PREGNANCY BE REDUCED?

Authors:  B S Cortis; G G Gensini
Journal:  Cardiovasc Dis       Date:  1977

Review 2.  Myocardial infarction in pregnancy.

Authors:  T E Nolan; G D Hankins
Journal:  Clin Obstet Gynecol       Date:  1989-03       Impact factor: 2.190

3.  Cocaine intoxication associated with abruptio placentae.

Authors:  D Flowers; J F Clark; L S Westney
Journal:  J Natl Med Assoc       Date:  1991-03       Impact factor: 1.798

Review 4.  Cocaine: maternal use during pregnancy and its effect on the mother, the fetus, and the infant.

Authors:  D Rosenak; Y Z Diamant; H Yaffe; E Hornstein
Journal:  Obstet Gynecol Surv       Date:  1990-06       Impact factor: 2.347

5.  Rupture of the ascending aorta during cocaine intoxication.

Authors:  C W Barth; M Bray; W C Roberts
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

6.  Acute myocardial infarction in a pregnant woman at term.

Authors:  W R Cohen; T Steinman; B Patsner; D Snyder; P Satwicz; P Monroy
Journal:  JAMA       Date:  1983-10-28       Impact factor: 56.272

7.  Subarachnoid hemorrhage precipitated by cocaine snorting.

Authors:  K A Schwartz; J A Cohen
Journal:  Arch Neurol       Date:  1984-07

8.  Myocardial ischemia and infarction related to recreational cocaine use.

Authors:  D L Coleman; T F Ross; J L Naughton
Journal:  West J Med       Date:  1982-05

9.  Incidence of electrocardiographic changes during cesarean delivery under regional anesthesia.

Authors:  C M Palmer; M C Norris; M C Giudici; B L Leighton; C A DeSimone
Journal:  Anesth Analg       Date:  1990-01       Impact factor: 5.108

10.  Acute cocaine poisoning. Importance of treating seizures and acidosis.

Authors:  S Jonsson; M O'Meara; J B Young
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

View more
  2 in total

1.  Ischaemic heart disease in pregnancy.

Authors:  Nabeel S Bondagji
Journal:  J Saudi Heart Assoc       Date:  2012-01-20

2.  Preoperative screening and case cancellation in cocaine-abusing veterans scheduled for elective surgery.

Authors:  Nabil Elkassabany; Rebecca M Speck; David Oslin; Mary Hawn; Khan Chaichana; John Sum-Ping; Jorge Sepulveda; Mary Whitley; Yasser Sakawi
Journal:  Anesthesiol Res Pract       Date:  2013-08-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.